2024 |
Novo Nordisk - ADR
|
Independent Director |
1.7 M |
-8.3 % |
2024 |
Charles River Laboratories International Inc.
|
Independent Director |
- |
- |
2024 |
SpringWorks Therapeutics Inc
|
Independent Director |
- |
- |
2024 |
Rallybio Corp
|
Chairman of the Board |
- |
- |
2023 |
Novo Nordisk - ADR
|
Independent Director |
1.8 M |
- |
2023 |
Charles River Laboratories International Inc.
|
Independent Director |
336.0 K |
1.9 % |
2023 |
Rallybio Corp
|
Executive Chairman of the Board |
- |
- |
2022 |
Charles River Laboratories International Inc.
|
Independent Director |
329.8 K |
3.7 % |
2022 |
Rallybio Corp
|
Chairman of the Board and Chief Executive Officer |
- |
- |
2022 |
Novo Nordisk - ADR
|
Independent Director |
- |
- |
2021 |
Charles River Laboratories International Inc.
|
Independent Director |
318.1 K |
-0.1 % |
2021 |
Novo Nordisk - ADR
|
Independent Director |
- |
- |
2021 |
Rallybio Corp
|
Chairman of the Board and Chief Executive Officer |
- |
- |
2020 |
Charles River Laboratories International Inc.
|
Independent Director |
318.4 K |
0.3 % |
2020 |
Novo Nordisk - ADR
|
Independent Director |
- |
- |
2020 |
Rallybio Corp
|
Chairman of the Board and Chief Executive Officer |
- |
- |
2019 |
Novo Nordisk - ADR
|
Independent Director |
1.4 M |
- |
2019 |
Charles River Laboratories International Inc.
|
Independent Director |
317.4 K |
15.4 % |
2018 |
Charles River Laboratories International Inc.
|
Independent Director |
275.0 K |
12.2 % |
2017 |
Charles River Laboratories International Inc.
|
Independent Director |
245.0 K |
- |